Sa Ra Lee

Title: Innovations of Sa Ra Lee in Alginic Acid-Folic Acid Conjugates

Introduction

Sa Ra Lee is an accomplished inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of methods for producing alginic acid-folic acid conjugates. His work focuses on enhancing the targeting of cancer cells, which is crucial for effective cancer treatment.

Latest Patents

Sa Ra Lee holds a patent for a "Method for producing alginic acid-folic acid conjugate, alginic acid-folic acid conjugate produced thereby and pharmaceutical composition containing the same." This innovative method utilizes a carboxy-protecting group and a leaving group to create an ester bond between the hydroxyl group of alginic acid and the carboxyl group of folic acid. The resulting alginic acid-folic acid conjugate is designed to more effectively target cancer cells compared to conventional methods, allowing for better differentiation between cancerous and normal tissues.

Career Highlights

Sa Ra Lee is affiliated with Seoul National University, where he continues to advance research in pharmaceutical sciences. His work has implications for precise cancer diagnosis and efficient surgical resection of cancer lesions, showcasing his commitment to improving healthcare outcomes.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Sa Ra Lee's innovative approach to producing alginic acid-folic acid conjugates represents a significant advancement in cancer treatment methodologies. His contributions are vital for the future of targeted cancer therapies.